At close: June 14 at 4:00 PM EDT
After hours: June 14 at 7:57 PM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
---|---|---|---|
EBSWORTH DAVID R Director | Purchase | Nov 6, 2023 | 844,643 |
EDWARDS MARTIN Director | Purchase | Nov 20, 2023 | 144,800 |
GUPTA RISHI Director | Sale | May 15, 2023 | -- |
HAHN MARK W. CPA Chief Financial Officer | Stock Award(Grant) | Oct 20, 2023 | 16,321,200 |
ORBIMED ADVISORS, L.L.C. Unknown | Sale | May 15, 2023 | -- |
POLL CLAIRE LOUISE General Counsel | Stock Gift | Feb 1, 2024 | 2,800,410 |
RICKARD KATHLEEN A Officer | Sale | May 3, 2024 | 2,621,550 |
SHAH MAHENDRA G Director | Sale | May 4, 2021 | 73,080 |
SINHA VIKAS CPA Director | Sale | May 4, 2021 | 74,440 |
ZACCARDELLI DAVID S Chief Executive Officer | Stock Award(Grant) | Oct 20, 2023 | 17,231,800 |
Related Tickers
URGN UroGen Pharma Ltd.
19.20
+9.71%
RCKT Rocket Pharmaceuticals, Inc.
21.86
-4.37%
ANVS Annovis Bio, Inc.
5.85
-2.66%
ARQT Arcutis Biotherapeutics, Inc.
8.63
-7.60%
MDGL Madrigal Pharmaceuticals, Inc.
277.59
+0.21%
CABA Cabaletta Bio, Inc.
10.66
-15.13%
IOVA Iovance Biotherapeutics, Inc.
8.16
-3.20%
GNFT Genfit S.A.
4.0900
-13.89%
VNDA Vanda Pharmaceuticals Inc.
6.24
-4.00%
AXSM Axsome Therapeutics, Inc.
73.63
+1.54%